Vhp Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -100.00%
- Profit Growth 37.26%
- Ebitda 59.82%
- Net Worth -132.86%
- Total Assets -17.32%
About Vhp Pharma
Vhp Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 2017 (Seven years and nine months 30 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Goyal and Rangoli Goel serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909UP2017PTC092078
-
Company No.
092078
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Apr 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Vhp Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Goyal
|
Director | 10-Apr-2017 | Current |
|
Rangoli Goel
|
Director | 01-Dec-2019 | Current |
Financial Performance of Vhp Pharma.
Vhp Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 37.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 132.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vhp Pharma?
Unlock access to Vhp Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pie Housing Private LimitedVishal Goyal and Rangoli Goel are mutual person
-
Katha Scales Private Limited
Vishal Goyal is a mutual person
-
Katha Energies Private Limited
Vishal Goyal is a mutual person
-
Aryav Infrabuild Private Limited
Vishal Goyal is a mutual person
-
De Style Art Interiors Private Limited
Vishal Goyal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vhp Pharma?
Unlock and access historical data on people associated with Vhp Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vhp Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vhp Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
